Downloads provided by UsageCountsBone sarcomas: ESMO–PaedCan–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up
Copyright policy ) Casali, P; Bielack, S; Abecassis, N; Aro, H; Bauer, S; Biagini, R; Bonvalot, S; Boukovinas, I; Bovee, J; Brennan, B; Brodowicz, T; Broto, J; Brugières, L; Buonadonna, A; De Álava, E; Dei Tos, A; Del Muro, X; Dileo, P; Dhooge, C; Eriksson, M; Fagioli, F; Fedenko, A; Ferraresi, V; Ferrari, A; Ferrari, S; Frezza, A; Gaspar, N; Gasperoni, S; Gelderblom, H; Gil, T; Grignani, G; Gronchi, A; Haas, R; Hassan, B; Hecker-Nolting, S; Hohenberger, P; Issels, R; Joensuu, H; Jones, R; Judson, I; Jutte, P; Kaal, S; Kager, L; Kasper, B; Kopeckova, K; Krákorová, D; Ladenstein, R; Le Cesne, A; Lugowska, I; Merimsky, O; Montemurro, M; Morland, B; Pantaleo, M; Piana, R; Picci, P; Piperno-Neumann, S; Pousa, A; Reichardt, P; Robinson, M; Rutkowski, P; Safwat, A; Schöffski, P; Sleijfer, S; Stacchiotti, S; Strauss, S; Sundby Hall, K; Unk, M; Van Coevorden, F; van der Graaf, W; Whelan, J; Wardelmann, E; Zaikova, O; Blay, J; ESMO Guidelines Committee, PaedCan and ERN EURACAN;
Bone sarcomas: ESMO–PaedCan–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up
Peer reviewed
Italy, United Kingdom, Netherlands, Italy, Italy, United Kingdom, Spain, Italy
- Spanish National Research Council Spain
- Olgahospital Germany
- Alma Mater Studiorum University of Bologna Italy
- Radboud University Nijmegen Netherlands
- St Anna Children's Hospital Austria
Adult, Biopsy, Medizin, CHILDRENS-ONCOLOGY-GROUP, Aftercare, Bone Neoplasms, Survivorship, Medical Oncology, Bone and Bones, POSITRON-EMISSION-TOMOGRAPHY, HIGH-DOSE CHEMOTHERAPY, Positron Emission Tomography Computed Tomography, Antineoplastic Combined Chemotherapy Protocols, GIANT-CELL TUMOR, Humans, Orthopedic Procedures, PRIMITIVE NEUROECTODERMAL TUMOR, Medical Oncology - Radboud University Medical Center, Radionuclide Imaging, STUDY-GROUP PROTOCOLS, Child, Societies, Medical, Neoplasm Staging, ta3126, Osteosarcoma, NONMETASTATIC EWINGS-SARCOMA, SOFT-TISSUE TUMORS, Incidence, Age Factors, Radboudumc 9: Rare cancers RIHS: Radboud Institute for Health Sciences, Hematology; Oncology, RANDOMIZED CONTROLLED-TRIAL, Long-Term Care, Magnetic Resonance Imaging, Neoadjuvant Therapy, Giant-cell tumor; ghildrens-oncology-group; high-grade osteosarcoma; nonmetastatic ewings-sarcoma; randomized controlled-trial; study-group protocols; soft-tissue tumors; primitive neuroectodermal tumor; positron-emission-tomography; high-dose chemotherapy, Europe, Self-Help Groups, Treatment Outcome, Radiotherapy, Adjuvant, EMC MM-03-86-01, Patient Participation, HIGH-GRADE OSTEOSARCOMA
Adult, Biopsy, Medizin, CHILDRENS-ONCOLOGY-GROUP, Aftercare, Bone Neoplasms, Survivorship, Medical Oncology, Bone and Bones, POSITRON-EMISSION-TOMOGRAPHY, HIGH-DOSE CHEMOTHERAPY, Positron Emission Tomography Computed Tomography, Antineoplastic Combined Chemotherapy Protocols, GIANT-CELL TUMOR, Humans, Orthopedic Procedures, PRIMITIVE NEUROECTODERMAL TUMOR, Medical Oncology - Radboud University Medical Center, Radionuclide Imaging, STUDY-GROUP PROTOCOLS, Child, Societies, Medical, Neoplasm Staging, ta3126, Osteosarcoma, NONMETASTATIC EWINGS-SARCOMA, SOFT-TISSUE TUMORS, Incidence, Age Factors, Radboudumc 9: Rare cancers RIHS: Radboud Institute for Health Sciences, Hematology; Oncology, RANDOMIZED CONTROLLED-TRIAL, Long-Term Care, Magnetic Resonance Imaging, Neoadjuvant Therapy, Giant-cell tumor; ghildrens-oncology-group; high-grade osteosarcoma; nonmetastatic ewings-sarcoma; randomized controlled-trial; study-group protocols; soft-tissue tumors; primitive neuroectodermal tumor; positron-emission-tomography; high-dose chemotherapy, Europe, Self-Help Groups, Treatment Outcome, Radiotherapy, Adjuvant, EMC MM-03-86-01, Patient Participation, HIGH-GRADE OSTEOSARCOMA
selected citations These citations are derived from selected sources.This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).477 popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.Top 0.1% influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).Top 1% impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.Top 0.1% views 38 downloads 31 - 38views31downloads
selected citations
Citations provided by BIP!
These citations are derived from selected sources.
This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).
Citations provided by BIP!popularityPopularity provided by BIP!
This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.
Popularity provided by BIP!influenceInfluence provided by BIP!
This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).
Influence provided by BIP!impulseImpulse provided by BIP!
This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.
Impulse provided by BIP!viewsViews provided by UsageCounts
Views provided by UsageCountsdownloadsDownloads provided by UsageCounts
Downloads provided by UsageCounts 477
Top 0.1%
Top 1%
Top 0.1%
38
31
Green
hybrid
